2021 Competing in the Global Sexually-Transmitted Disease (STD) Testing Market: Supplier Shares and Strategies, Segment Volume and Sales Forecasts for Major Assays, Emerging Technologies and Trends, Growth Opportunities for Suppliers

This new 350-page report contains 90 tables and provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

The report is available by section, and can be customized to specific information needs and budget.

The report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales forecasts by country and market segment, including:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs      

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test and country.  Also, the report:

     -  Examines market applications of Molecular Diagnostics,  
        Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

     -  Reviews features and operating characteristics of major analyzers used 
        for STD testing;

     -  Profiles key suppliers and potential market entrants developing innovative
        technologies and products; and

     -  Analyzes emerging opportunities, alternative market penetration strategies, 
         market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as ’s proprietary data files was conducted.


I. Introduction
II. Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Human Herpes Virus-6 (HHV-6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Papillomavirus (HPV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens
Healthineers, Tosoh, and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. France: Market Size, Growth and Major Suppliers’
Sales and Market Shares
IV. Germany: Market Size, Growth and Major Suppliers’
Sales and Market Shares
V. Italy: Market Size, Growth and Major Suppliers’
Sales and Market Shares
VI. Japan: Market Size, Growth and Major Suppliers’
Sales and Market Shares
VII. Spain: Market Size, Growth and Major Suppliers’
Sales and Market Shares
VIII. UK: Market Size, Growth and Major Suppliers’
Sales and Market Shares
IX. USA: Market Size, Growth and Major Suppliers’
Sales and Market Shares

Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic

- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako


List Of Tables


Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Pap Smear/HPV Tests
Major Companies Developing or Marketing Syphilis Tests
France
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Chlamydia Diagnostics Sales by Major Supplier
France
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
France
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Herpes Type VI Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Herpes Testing Market Diagnostics Sales
by Major Supplier

France
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Papillomavirus (HPV) Test Volume and Diagnostics Sales
Forecast by Market Segment
France
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Syphilis Testing Market Diagnostics Sales
by Major Supplier
Germany
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Germany
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany
Herpes Type VI Test Volume and Diagnostics Sales Forecast
by Market Segment

Germany
Herpes Testing Market Diagnostics Sales
by Major Supplier
Germany
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Italy
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy
Herpes Type VI Test Volume and Diagnostics Sales Forecast
by Market Segment

Italy
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Chlamydia Diagnostics Sales by Major Supplier
Japan
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Japan
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan
Herpes Testing Market Diagnostics Sales
by Major Supplier

Japan
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Syphilis Testing Market Diagnostics Sales
by Major Supplier
Spain
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Chlamydia Diagnostics Sales by Major Supplier
Spain
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain
Herpes Type VI Test Volume and Diagnostics Sales Forecast
by Market Segment

Spain
Herpes Testing Market Diagnostics Sales
by Major Supplier
Spain
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Syphilis Testing Market Diagnostics Sales
by Major Supplier
U.K.
Chancroid
Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.K.
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment

U.K.
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K.
Herpes Testing Market Diagnostics Sales
by Major Supplier
U.K.
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K.
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Syphilis Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Chancroid Diagnostics Sales by Major Supplier
U.S.A.
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Chlamydia Diagnostics Sales by Major Supplier

U.S.A.
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Herpes Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Syphilis Testing Market Diagnostics Sales
by Major Supplier


2021 Allscripts Healthcare Solutions Strategic SWOT Analysis--Performance, Capabilities, Goals and Strategies in the Global Healthcare Industry

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the

USD 750 View Report

2021 Welltower Strategic SWOT Analysis--Performance, Capabilities, Goals and Strategies in the Global Healthcare Industry

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the

USD 750 View Report

2021 Competing in the Global Drug of Abuse Testing Market: Supplier Shares and Strategies, Segment Volume and Sales Forecasts for 12 Assays, Emerging Technologies and Trends, Growth Opportunities for Suppliers

This new 318-page report from contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market

USD 7500 View Report

2021 Competing in the Global Immunoprotein Testing Market: Supplier Shares and Strategies, Segment Volume and Sales Forecasts for 13 Assays, Emerging Technologies and Trends, Growth Opportunities for Suppliers

This new 297-page report from contains 72 tables and provides analysis of the global immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and

USD 7500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available